Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HK-660S in Primary Sclerosing Cholangitis
NCT05866809Phase 2Completed
- Sponsor
- Curome Biosciences
- Start
- Oct 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapachone in Primary Sclerosing Cholangitis (PSC), sponsored by Curome Biosciences. Started Oct 2021; status: completed.
02
Drugs
lapachone
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT05866809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05866809.